Virtus ETF Advisers’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Virtus ETF Advisers’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-155,009	Closed	-$527K	–	424
2018 Q3	$527K	Buy	155,009 +10,445	+7%	+$37.7K	0.05%	117
2018 Q2	$544K	Sell	144,564 -54,525	-27%	-$265K	0.48%	135
2018 Q1	$814K	Sell	199,089 -11,577	-5%	-$53.9K	0.71%	70
2017 Q4	$980K	Buy	210,666 +53,601	+34%	+$295K	1.23%	25
2017 Q3	$1.11M	Hold	157,065	–	–	0.15%	54
2017 Q2	$1.14M	Sell	157,065 -26,842	-15%	-$168K	0.17%	41
2017 Q1	$1.13M	Buy	183,907 +17,684	+11%	+$96.9K	0.2%	55
2016 Q4	$974K	Buy	166,223 +60,346	+57%	+$330K	0.29%	54
2016 Q3	$562K	Buy	105,877 +13,341	+14%	+$71.9K	0.27%	65
2016 Q2	$613K	Sell	92,536 -43,936	-32%	-$246K	0.45%	27
2016 Q1	$637K	Hold	136,472	–	–	0.88%	24
2015 Q4	$689K	Buy	+136,472	New	+$648K	1.89%	9

Virtus ETF Advisers's KERX Position: Q4 2018 in Review

Virtus ETF Advisers sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 155,009 shares — an estimated $527K sold.

Virtus ETF Advisers first reported a position in KERX in Q4 2015 and held it in 12 quarters. The position peaked at $1.14M in Q2 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Virtus ETF Advisers reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Virtus ETF Advisers sold 155,009 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $527K.
Virtus ETF Advisers first reported a position in Keryx Biopharmaceuticals Inc in Q4 2015 and held it in 12 quarters.
Virtus ETF Advisers's Keryx Biopharmaceuticals Inc position peaked at $1.14M in Q2 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Virtus ETF Advisers's 13F filing for Q4 2018, filed 5 Feb 2019.